Adriana Gambardella

Adriana joined Medicines Discovery Catapult in 2023, supporting SMEs to develop strategies and de-risk drug discovery programmes. She brings extensive translational R&D experience across oncology, inflammation, and fibrosis from academia, biotech, and CROs. Following a PhD at EMBL, Italy, and postdoctoral fellowships at Edinburgh and Oxford, she led target validation and immunology teams at Immunocore and Concept Life Sciences, before driving fibrosis and immunology programmes as Project Leader and Lead Translational Scientist at Redx, including Phase I Crohn’s disease and Phase IIa idiopathic pulmonary fibrosis studies.